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Abstract
Background : Brugada syndrome is an inherited disease characterized by an increased risk of sudden cardiac death owing to ventricular 
arrhythmias in the absence of structural heart disease. It has been reported that this syndrome is more prevalent in South-East Asia 
than in Western countries. Furthermore, genetic studies showed important contributions of several gene mutations to the phenotype 
of BrS. These suggest that ethnic difference play significant roles in the pathogenesis of BrS. In addition, ICD implantation remains the 
cornerstone management with a low rate of appropriate shocked. Therefore, it is important to investigate patients’ characteristics for 
risk stratification. Our objective to investigate the clinical, electrocardiography (ECG) and electrophysiological characteristics that can 
be used as a predictor of appropriate shock due to ventricular arrhythmia (VA) in Indonesian patients with BrS.
Methods: We analyze data from Brugada syndrome registry at National Cardiovascular Centre Harapan Kita from January 2013 until 
September 2016. Total of 22 patients was included. Characteristics of BrS that we analyzed were baseline characteristics (age and sex), 
Clinical finding (syncope, cardiac arrest), ECG finding (spontaneous type 1 or drug induced) and Electrophysiology study result (inducible 
VA and RV ERP). We also added some new ECG characteristic (S wave in lead 1, S wave duration in V1, Fragmented QRS, Junction ST 
elevation and early repolarization pattern in inferolateral) to be analyzed. Our end point is appropriate shock during ICD interrogation 
for those who have been implanted an ICD and documented VA for those who didn’t receive ICD.
Results: We found a high incidence of appropriate ICD’s shock in our population (50% in our study vs 5-11.5% in the real world). 
Predictors of appropriate shock and documented VA are history of syncope (p = 0.045), spontaneous type-1 ECG (p = 0.0437) and 
right ventricular effective refractory period (RV ERP) of <200 ms (p=0.018). Other parameters that have been reported to correlate 
with the occurrence of VA (S Wave in lead 1 (p = 0.433), early repolarization pattern (p = 0.462), fragmented QRS (p = 0.460), S Wave 
duration (p = 0.365) and J Point STE (p = 0.800) were found to be not correlated to appropriate shock in our populations. 
Conclusion: History of syncope, spontaneous type-1 Brugada ECG and RV ERP of <200 ms have predictive values for risk stratification 
of Indonesian patients with Brugada syndrome.
(Indonesian J Cardiol. 2019;40:243-248)
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Introduction
Brugada syndrome (BrS) is highly correlated with the unpredicted event of Sudden Cardiac Death (SCD) due to ventricular fibrillation (VF) (1). Found in patients with seemingly 
structurally normal hearts. It has hallmark ECG 
sign of coved ST-segment elevation in V1 until V3 
doi: 10.30701/ijc.v40i2.767
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(right precordial lead) (2). It categorized as genetically 
inherited disorders and characterized with specific gene 
mutations. SCN5A is the first site of mutation that had 
been found. SCN5A manage the sodium channels, that 
had an important role in cardiac cell depolarization. 
In recent years, >100 mutations have been reported 
(3,4). By manipulating the alpha subunit of the sodium 
channels it causes spatial dispersion of the epicardial 
and endocardial depolarization (5). The prevalence 
of BrS relatively unique, it has a low prevalence in a 
western country. But higher in Asian. It is reported that 
the prevalence was 1.2% in Japan, 0.17% in Filipinos, 
0.13% in Taiwanese, 0.9% in Korean and 3.1% in 
Singaporean (1,6). Ethnic-related genetic polymorphisms 
believed to take responsibility to that different.7
 Implantable Cardiac Defibrillator (ICD) remains 
the cornerstone management to avoid sudden death. 
While the role of Radiofrequency (RF) ablation in BrS 
are still debatable. The incidence of appropriate shock 
in a patient with ICD is relatively low, from a various 
study it ranges from 5-11.5%.In the recent metanalysis 
that published in AHA 2019 involving a large number 
of patient (1500 patients) with the ICD as a primary 
prevention, the appropriate ICD shock was delivered in 
18 % patient. Not too high, moreover if we compared 
with the inappropriate ICD shock rate that as much as 
15 % of all patient. Concern to choose which patients 
who are at risk and deserved ICD implantation is remain 
the subject of interest of BrS management.  
 In the era of universal health coverage in Indonesia, 
it becomes urgently needed our own risk stratification 
for BrS. So we can get the larger benefit of the 
ICD implantation and reducing the inappropriate 
implantation and inappropriate ICD’s shock. We 
combine several patient characteristics that can be 
used as predictors from the various study. We put it all 
together and trying to get the best predictors for our 
Indonesian’s specific subset of the patient.
Methods
Study Design and Patient  Selection
This is an observational retrospective study. We analyze 
data from Brugada syndrome registry at National 
Cardiovascular Centre Harapan Kita from January 
2013 until September 2016. Data were taken from 
medical record investigation. Patient ICD’s record 
reinvestigation was performed if needed. The median 
follow up period were 27 months. Patients with 
incomplete medical records and incomplete follow up 
after the diagnosis was excluded. 
Predictor Characteristics
Characteristics of BrS that we analyzed were a 
combination of clinical, ECG finding and EP study 
result characteristics. Baseline characteristics such as age 
and sex were included. Another clinical finding, history 
of syncope and cardiac arrest also counted. 
 Characteristics of ECG finding were reviewed and 
classified, whether its Spontaneous type 1 ECG pattern 
(according to consensus criteria) or not. For type 2 and 
type 3 ECG pattern, we performed a provocation test 
(using ajmaline). We also included some ECG  predictor 
that has been proposed by another study before, such as: 
- S wave in lead 1 divined as an S wave amplitude ≥ 
0.1 mV and duration ≥ 40 ms
- S wave duration in V1 
- Fragmented QRS divined as numerous morpholo-
gies of the QRS wave with or without a Q wave, 
which had the presence of an additional R wave 
(R’) or notching in the nadir of the R wave or the S 
wave, or the presence of >1 R’ (fragmentation) in 2 
contiguous leads
- J Junction ST elevation, we measured ST-segment 
elevation in leads V1 and V2 because there is usually 
a prominent r’ in Brugada syndrome and either of 
these 2 leads shows the maximum ST-segment ele-
vation
- Early repolarization pattern in inferolateral charac-
terized by an elevation of the J-point, either as QRS 
slurring or notching of ≥ 0.1 mV in ≥ 2 consecutive 
inferior leads (II, III, and aVF) or lateral leads (I, 
aVL, V5, and V6)
 
Electrophysiology study result that used for data analysis 
are :
- Right, Ventricular Effective Refractory Period (RV 
ERP), classified as ≤ 200 ms or not. We used a 
standard protocol to evaluate the ERP, using pro-
grammed ventricular stimulation.
- Ventricular arrhythmia (VA) Inducibility, any sus-
tained VA that induced by standard protocols of 
ventricular extra stimulation pacing (S1 until S4).
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 Our end point is at least one episode of ventricular 
arrhythmia (VA) that noted during ICD interrogation 
or at least one ICD therapy (shock or Anti Tachycardia 
Pacing) for those who have been implanted an ICD and 
documented VA or SCD for those who didn’t receive 
ICD.
Data Analysis
Statistical analyses were done by statistical software 
SPSS. Continuous variables are reported as mean 
standard deviation. Categorical variables are reported as 
number (percentage). 
Results
A total of 28 consecutive patient that was being 
diagnosed as Brugada Syndrome since January 2013. 
Seven patient was confirmed has type 1 Brugada ECG 
pattern, while another 21 has type 2 and 3 Brugada ECG 
pattern. From those who had type 2 and 3, 6 patients 
were excluded, because the result of provocation test was 
negative, and no further follow up was found. The final 
study population was 22 patients. Most are male, 19 
patients (86,36%) and ranged from 27 to 55 years old.
Clinical characteristic
During follow up, seven patients (31.8 %) proceeded 
to undergone ICD implantation. While another is 
treated conventionally. ICD interrogation performed 
periodically or whenever they had suggestive symptoms. 
From those who had  ICD implanted, 4 patient known 
to be had VA event in their ICD’s interrogation. And 
all of the events successfully treated by their ICD (with 
ATP/Anti Tachycardia Pacing or defibrillation). From 
all ICD that has been implanted no inappropriate ICD’s 
shock was detected.
 Another group that didn’t get ICD (14 patients) 
were also being monitored. Careful medical record 
follows up were performed. None of them are had any 
VA or SCD event during follow up period.
 Clinical characteristics. Significant difference only 
found in the history of Syncope. History of previous 
syncope had strong correlation with the occurrence 
of ICD shock or Ventricular arrhythmia (p = 0.045). 
While another clinical predictors such as sex Male (p = 
0.460); age (p = 0.365) ; palpitation (p = 0.246) ; family 
history of SCD (p 0 = 0.397) didn’t had significance 
relationship with ICD’s shock / VA.
Table 1 . Patient’s clinical characteristics as a predictor of ICD 
Shock or Ventricular Arrhythmia
Variables
Event
(ICD Shock / Ventricular 
Arrhythmia) P value
Yes (n=4) No (n=18)
Sex : Male 4 (100 %) 15 (83.33%) 0.460
Age 50.25±4.85 44.17±12.70 0.365
History of Syncope 4 (100 %) 7 (38.89 %) 0.045
Palpitation 2 (50 %) 4 (22.22 %) 0.246
Family History of 
SCD 1 (25 %) 2 (1.22 %) 0.397
ECG Characteristics
There are six ECG characteristics that we had analyzed. 
Type 1 Brugada ECG pattern had a strong correlation 
with the occurrence of ICD shock / VA in the future 
(p = 0.005). Another five new ECG characteristics 
found that there was no significant correlation with our 
endpoint. S wave in lead 1 (p = 0.433), S wave duration 
in V1 (p = 0.392), fragmented QRS (p = 0.460), J 
Junction ST elevation (p = 0.80) and infero-lateral early 
repolarization pattern (p = 0.462).
Table 2 . ECG  characteristics as a predictor of ICD Shock or 
Ventricular Arrhythmia
Variables
Event
(ICD Shock / Ventricular 
Arrhythmia) P value
Yes (n=4) No (n=18)
Type 1 Brugada 
ECG Pattern 4 (100 %) 3 (16.67 %) 0.0043
S wave in lead 1 1 (25 %) 3 16.67 %) 0.433
S wave duration in V1 0.053 ± 0.011 0.044 ± 0.016 0.392
fragmented QRS 1 (25 %) 4 (22.22 %) 0.460
J Junction ST 
elevation 1.33 ± 0.57 1.44 ± 0.68 0.800
Early repolarization 
pattern 0 (0%) 3 (16.67 %) 0.460
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Electrophysiology Study Result
Electrophysiology Study (EPS) was focused mainly on 3 
things. The first is VA inducibility during EPS. Inducible 
VA defined as sustained Ventricular Tachycardia (VT) 
with hemodynamically stable for more than 30 second 
or any VT/VF with hemodynamically unstable that need 
electrical defibrillation. The second things that being 
analyzed were a number of extra stimuli to produce the 
VA event. And the third was the effective Refractory 
Period of the RV (RV ERP). 
 VA was induced in 5 patients, but there was no 
significant difference between the two groups. Those 
who will have any VA/SCD event in the future, VA was 
induced in 2 patients (40%). And 3 (60%) in patients 
that will not have any event in the future (p = 0.234). 
Number of extra stimuli to produce the VA was also not 
statistically significant (p = 0.120). 
 While patient that will have any VA/SCD event 
during follow up period had significantly (p = 0.018) 
lower RV ERP value (190.0 ± 0.01 ms) compared to 
those who will not have any event (222.5 ± 14.80 ms).
Discussion
Overall sudden cardiac events rate during follow up in 
this study are 4 out of 22 (18.18 %). It was higher if 
compared to another study. Such as study by Brugada 
et all 2003, the cardiac events rate is only 45 of the 547 
individuals (8.2%). PRELUDE study, the large registry 
that published in 2012, also had lower cardiac events 
rate 14 of 208 (4.5 %). But it's comparable to the recent 
meta-analysis, the ICD’s shock delivered in the 18 % of 
the population. Larger incidence of events rate can be 
caused by several factors. It had been told that the Asian 
region had a slightly higher prevalence of BrS, it may 
contribute to a higher incidence of cardiac events too 
(8). The other factors may be due to too selective cases 
selection. As we know, our center (NCCHK) is tertiary/
top referral cardiac center, it means cases are naturally 
had been selected. 
 The most important thing in BrS management is 
defining which patient will get the benefit of The ICD 
implantation since it was still the only cornerstone 
management to date. For cardiac arrest survivor, ICD 
implantation as secondary prevention is had no doubt 
(9,10). The grey area laid in primary prevention. We try 
to combine all BrS characteristics that previously found 
to be had a correlation with the incidence of SCD, 
ventricular arrhythmia or ICD’s appropriate shock in the 
future. From all modalities, from clinical characteristics 
to sophisticated Electrophysiology Study result. 
 From clinical characteristics, we found that only the 
history of the previous syncope is the predictor of VA or 
SCD during follow up. This finding similar to several 
previous studies. Patients with symptoms (syncope of 
unknown origin) and spontaneous coved-type ST-
segment elevation are at risk for future arrhythmic 
events. However, risk stratification in asymptomatic 
cases is still not defined. 
 Although it was well known that male sex and 
family history of BrS was found previously to have an 
important part in the diagnostic process, we found that 
it didn’t have any correlation with future arrhythmia 
event. It can be said that making a diagnosis and making 
risk stratification for BrS is two different things.   
 The Result of this study is quite similar to other 
previous large studies. Compared to two well-known 
previous studies, PRELUDE and study by Brugada et 
all 2003. History of syncope and spontaneous type 1 
ECG pattern are two characteristics that meet all the 
study. (11,12). In our study, we found that the value of 
RV ERP can be used as a predictor of a future cardiac 
event. The lower value of RV ERP and not the inducible 
arrhythmia had a higher probability of future cardiac 
events. It is matched to PRELUDE. While f-QRS that 
proven to be had a correlation in PRELUDE, we found 
that it not statistically significant. 
This Study Brugada et al, 2003 PRELUDE registry
History of Syncope History of Syncope History of Syncope
Spontaneous Type 1 
Brugada ECG
Spontaneous Type 1 
Brugada ECG
Spontaneous Type 1 
Brugada ECG
RV ERP VT/VF inducibility 
during EPS
f-QRS
Conclusion
A patient who had a higher probability of future cardiac 
events are patient with spontaneous type 1 BrS ECG 
pattern, history of syncope and lower RV ERP result 
during EP study. Those are patient subsets that are 
believed to had the most benefit of ICD implantation 
as primary prevention. 
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Study Limitation
This study has several limitations. First, a small number 
of patients that being followed up and being implanted 
with an ICD. Second, we can’t provide additional data 
that may be useful in the analysis, such as concomitant 
rhythm disorders, structural heart disease, and gene 
analysis.
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